MedDataX Logo

Effectiveness of Anti-Psychotic in GPs Setting

NCT ID: NCT00543088

Last Updated: 2009-04-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on Quality of Life of GP-based management of antipsychotic treatment in Belgium

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality of Life in Schizophrenic Patients

NCT00597168

Schizophrenia
COMPLETED

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

NCT03164876

Schizophrenia
COMPLETED PHASE1

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

NCT00528905

Schizophrenia
COMPLETED PHASE2

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

NCT01160679

Schizophrenia
COMPLETED

The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

NCT04076371

Schizophrenia
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with Schizophrenia or Bipolar Disorder (currently in a manic episode)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pitchot W Pr

Role: PRINCIPAL_INVESTIGATOR

ULg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Baudour, , Belgium

Site Status

Research Site

Beyne-Heysay, , Belgium

Site Status

Research Site

Bomal, , Belgium

Site Status

Research Site

Bredene, , Belgium

Site Status

Research Site

Brussels, , Belgium

Site Status

Research Site

Esen, , Belgium

Site Status

Research Site

Evere, , Belgium

Site Status

Research Site

Gingelom, , Belgium

Site Status

Research Site

Gouy-lez-Piéton, , Belgium

Site Status

Research Site

Grâce-Hollogne, , Belgium

Site Status

Research Site

Gullegem, , Belgium

Site Status

Research Site

Harelbeke, , Belgium

Site Status

Research Site

Harre, , Belgium

Site Status

Research Site

Hotton, , Belgium

Site Status

Research Site

Houtvenne, , Belgium

Site Status

Research Site

Incourt, , Belgium

Site Status

Research Site

Ixelles-Elsene, , Belgium

Site Status

Research Site

Jalhay, , Belgium

Site Status

Research Site

Jette, , Belgium

Site Status

Research Site

Keumiée, , Belgium

Site Status

Research Site

Lembeke, , Belgium

Site Status

Research Site

Liège, , Belgium

Site Status

Research Site

Limbourg, , Belgium

Site Status

Research Site

Longueville, , Belgium

Site Status

Research Site

Lovendegem, , Belgium

Site Status

Research Site

Malmedy, , Belgium

Site Status

Research Site

Mechelen, , Belgium

Site Status

Research Site

Monceau-sur-Sambre, , Belgium

Site Status

Research Site

Montignies-sur-Sambre, , Belgium

Site Status

Research Site

Moorsel, , Belgium

Site Status

Research Site

Moorseled, , Belgium

Site Status

Research Site

Mouscron, , Belgium

Site Status

Research Site

Namur, , Belgium

Site Status

Research Site

Oostrozebeke, , Belgium

Site Status

Research Site

Ostend, , Belgium

Site Status

Research Site

Oudenaarde, , Belgium

Site Status

Research Site

Poperinge, , Belgium

Site Status

Research Site

Ransart, , Belgium

Site Status

Research Site

Roux, , Belgium

Site Status

Research Site

Ruisbroek, , Belgium

Site Status

Research Site

Schaarbeek, , Belgium

Site Status

Research Site

Spa, , Belgium

Site Status

Research Site

Staden, , Belgium

Site Status

Research Site

Theux, , Belgium

Site Status

Research Site

Tilleur, , Belgium

Site Status

Research Site

Torhout, , Belgium

Site Status

Research Site

Tubize, , Belgium

Site Status

Research Site

Verviers, , Belgium

Site Status

Research Site

Veurne, , Belgium

Site Status

Research Site

Wachtebeke, , Belgium

Site Status

Research Site

Willebroek, , Belgium

Site Status

Research Site

Wilrijk, , Belgium

Site Status

Research Site

Woluwe-St-Lambert, , Belgium

Site Status

Research Site

Zeebrugge, , Belgium

Site Status

Research Site

Zichem, , Belgium

Site Status

Research Site

Zomergem, , Belgium

Site Status

Research Site

Zonnebeke, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRP-NB-SER-2006/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064 COMPLETED
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 UNKNOWN
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCT01164059 COMPLETED PHASE4
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 COMPLETED
The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers
NCT00612079 COMPLETED NA
Study of Mental Care in Spain
NCT00824031 COMPLETED
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 UNKNOWN PHASE4
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893 COMPLETED
Safety and Tolerability of BI 409306 in Patients With Schizophrenia
NCT01892384 COMPLETED PHASE1
Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms
NCT02529163 UNKNOWN NA
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 UNKNOWN
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
NCT04510298 COMPLETED PHASE1
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 COMPLETED NA
A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly
NCT03809325 COMPLETED
Study on the Efficacy and Safety of QLM1016 in Schizophrenia
NCT06799559 NOT_YET_RECRUITING PHASE3
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
NCT03911726 ACTIVE_NOT_RECRUITING NA
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
NCT03356639 COMPLETED PHASE1
Psychiatric Orders in Psychoanalytic Treatment of ASD
NCT05930912 UNKNOWN
Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
NCT00570063 TERMINATED PHASE2
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
NCT00833456 COMPLETED
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05958875 RECRUITING PHASE4
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
NCT02409823 COMPLETED
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
NCT04092686 COMPLETED PHASE3
Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia.
NCT03801551 COMPLETED NA
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
NCT00488163 COMPLETED PHASE4